Compare · CON vs ELV
CON vs ELV
Side-by-side comparison of Concentra Group Holdings Parent Inc. (CON) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CON and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $87.86B, about 25.8x CON ($3.41B).
- Over the past year, CON is up 21.4% and ELV is up 6.2% - CON leads by 15.2 points.
- ELV has been more active in the news (4 items in the past 4 weeks vs 3 for CON).
- ELV has more recent analyst coverage (23 ratings vs 12 for CON).
- Company
- Concentra Group Holdings Parent Inc.
- Elevance Health Inc.
- Price
- $26.62+1.99%
- $404.50-4.68%
- Market cap
- $3.41B
- $87.86B
- 1M return
- +6.52%
- +5.98%
- 1Y return
- +21.39%
- +6.15%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2024
- News (4w)
- 3
- 4
- Recent ratings
- 12
- 23
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest CON
- Goldman initiated coverage on Concentra with a new price target
- Director Ortenzio Robert A sold $3,250,026 worth of shares (130,000 units at $25.00) (SEC Form 4)
- SEC Form 144 filed by Concentra Group Holdings Parent Inc.
- Director Ortenzio Robert A sold $3,250,000 worth of shares (130,000 units at $25.00) (SEC Form 4)
- SEC Form 144 filed by Concentra Group Holdings Parent Inc.
- SEC Form 10-Q filed by Concentra Group Holdings Parent Inc.
- Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Concentra Group Holdings Parent, Inc. Announces Results for Its First Quarter Ended March 31, 2026, Cash Dividend, and Raised FY 2026 Guidance
- Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
Latest ELV
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)
- Elevance Health upgraded by Deutsche Bank with a new price target
- Director Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)
- Director Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)
- Director Peru Ramiro G was granted 563 shares, increasing direct ownership by 6% to 9,908 units (SEC Form 4)
- Director Neri Antonio F was granted 563 shares, increasing direct ownership by 11% to 5,488 units (SEC Form 4)
- Director Jallal Bahija was granted 563 shares, increasing direct ownership by 12% to 5,351 units (SEC Form 4)
- Director Hay Lewis Iii was granted 563 shares, increasing direct ownership by 5% to 12,070 units (SEC Form 4)